Irbesartan reduces creatinine clearance in type 1 diabetic children with renal hyperfunction: a randomized, double-blind, placebo-controlled trial. [electronic resource]
Producer: 20051202Description: 2120-5 p. digitalISSN:- 0931-0509
- Adolescent
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Biphenyl Compounds -- therapeutic use
- Child
- Creatinine -- urine
- Diabetes Mellitus, Type 1 -- drug therapy
- Diabetic Nephropathies -- drug therapy
- Double-Blind Method
- Humans
- Irbesartan
- Kidney -- drug effects
- Tetrazoles -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.